Why Cancom SE (ETR:COK) Could Be Worth Watching

While Cancom SE (ETR:COK) might not be the most widely known stock at the moment, it received a lot of attention from a substantial price increase on the XTRA over the last few months. As a stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. But what if there is still an opportunity to buy? Let’s examine Cancom’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.

Check out our latest analysis for Cancom

Advertisement

Is Cancom Still Cheap?

According to my valuation model, Cancom seems to be fairly priced at around 8.81% above my intrinsic value, which means if you buy Cancom today, you’d be paying a relatively reasonable price for it. And if you believe that the stock is really worth €27.92, then there isn’t really any room for the share price grow beyond what it’s currently trading. So, is there another chance to buy low in the future? Given that Cancom’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us an opportunity to buy later on. This is based on its high beta, which is a good indicator for share price volatility.

Can we expect growth from Cancom?

earnings-and-revenue-growth
XTRA:COK Earnings and Revenue Growth November 28th 2022

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to grow by 44% over the next couple of years, the future seems bright for Cancom. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What This Means For You

Are you a shareholder? It seems like the market has already priced in COK’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?

Are you a potential investor? If you’ve been keeping tabs on COK, now may not be the most optimal time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. Every company has risks, and we've spotted 2 warning signs for Cancom (of which 1 makes us a bit uncomfortable!) you should know about.

If you are no longer interested in Cancom, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About XTRA:COK

Cancom

Provides information technology services in Germany and internationally.

Flawless balance sheet, good value and pays a dividend.

Advertisement

Weekly Picks

LO
Lou_Basenese
GIFT logo
Lou_Basenese on Giftify ·

Giftify ($GIFT): A Small-Cap Incentives Platform with More ScaleThan Its Valuation Suggests

Fair Value:US$2.563.5% undervalued
55 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative
HA
HarishPK
LULU logo
HarishPK on lululemon athletica ·

Quantifying the Transition: Why Lululemon’s Moat Remains Intact

Fair Value:US$161.826.3% undervalued
22 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
TR
tripledub
GOOGL logo
tripledub on Alphabet ·

Warren Buffett Just Bet $10 Billion on Google. The Catch? You May Already Be Too Late.

Fair Value:US$23055.3% overvalued
59 users have followed this narrative
1 users have commented on this narrative
16 users have liked this narrative
JO
John_Eric
VEEV logo
John_Eric on Veeva Systems ·

AI-Powered Veeva Systems Poised for Solid Growth Amid Regulatory Stability

Fair Value:US$32040.6% undervalued
32 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

RO
RockeTeller
AAG logo
RockeTeller on Aftermath Silver ·

Aftermath Silver, A 35% Insider-Aligned Silver Stock With a Giant Critical Metals Twist

Fair Value:CA$30.3797.8% undervalued
6 users have followed this narrative
2 users have commented on this narrative
1 users have liked this narrative
ES
NVR logo
Esteban on NVR ·

NVR 05-2026

Fair Value:US$3.76k72.4% overvalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
AnimalDoctorKwon
CAPR logo
AnimalDoctorKwon on Capricor Therapeutics ·

The Exosome Pioneer: Why Capricor (CAPR) is Poised for an August FDA Breakthrough

Fair Value:US$5862.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75029.8% undervalued
87 users have followed this narrative
1 users have commented on this narrative
9 users have liked this narrative
BL
BlackGoat
CBRS logo
BlackGoat on Cerebras Systems ·

The Wafer Giant Threatening NVIDIA's GPU Hegemony

Fair Value:US$415.5448.2% undervalued
60 users have followed this narrative
3 users have commented on this narrative
11 users have liked this narrative
TR
tripledub
GOOGL logo
tripledub on Alphabet ·

Warren Buffett Just Bet $10 Billion on Google. The Catch? You May Already Be Too Late.

Fair Value:US$23055.3% overvalued
59 users have followed this narrative
1 users have commented on this narrative
16 users have liked this narrative